Joan Mannick, MD

Chief Medical Officer
resTORbio, Inc
Boston, MA

Disclosure: resTORbio: Employee, Shareholder

Presentation(s):

• LB2 - TORC1 Inhibition with RTB101 as a Potential Pan-Antiviral Immunotherapy to Decrease the Incidence of Respiratory Tract Infections Due to Multiple Respiratory Viruses in Older Adults

  Thursday, October 3
  1:55 PM – 2:05 PM